UX701

· Ultragenyx Pharmaceutical Inc

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for UX701, covering 2026-03-13 to 2026-03-13. Get the full timeline:

Most recent: Clinical Trial Update: A Phase 1/2/3 Study of UX701 Gene Therapy in Adults With Wilson Disease [Phase 1, Phase 2]